Clinical trial
Evaluation of Vitrase as a Spreading Agent
NCT00198484 · Bausch & Lomb Incorporated, Industry · Completed
Key facts
| NCT number | NCT00198484 |
|---|---|
| Title | Evaluation of Vitrase as a Spreading Agent |
| Official title | Evaluation of Vitrase (Hyaluronidase for Injection) Ovine, 200 USP Units/mL, as an Adjuvant to Increase the Absorption and Dispersion of Other Injected Drugs Prior to Ocular Surgery |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | Vitrase |
| Enrollment | 108 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2004 |
| Completion | Feb 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 14, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: